Hong Kong-listed innovative drug stocks fluctuated and strengthened, with Zai Lab (09688.HK) rising more than 5%, Lepu Biopharma (02157.HK) rising more than 4%, and Akeso Biopharma (09926.HK) and CSPC Pharmaceutical Group (01093.HK) following suit.
2026-08-13
Hong Kong-listed innovative drug stocks fluctuated and strengthened, with Zai Lab (09688.HK) rising more than 5%, Lepu Biopharma (02157.HK) rising more than 4%, and Akeso Biopharma (09926.HK) and CSPC Pharmaceutical Group (01093.HK) following suit.